-
Apr 10, 2026Prisys Biotech Supports IND Approval Of UX-GIP001 By FDA And CDE | NHP CNS De...UX-GIP001, an iPSC-derived cell therapy by UniXell Biotechnology, receives IND approvals from FDA and CDE. Prisys Biotech supports CNS delivery using NHP models and MRI-guided C... -
Apr 02, 2026In Vivo Immune Cell Tracking & PET Tracer Development in NHP Models | Prisys ...Explore how Prisys Biotech enables in vivo immune cell tracking and PET tracer development using NHP models and clinical-grade imaging platforms to accelerate translational drug... -
Mar 31, 2026Dopamine Transporter PET Imaging in NHP Models | CNS Imaging | Prisys BiotechExplore high-precision CNS imaging using dopamine transporter PET and hybrid PET/MRI in non-human primate models. Prisys Biotech enables quantitative, translational neuroimaging... -
Mar 27, 2026PET/CT Biodistribution in NHP Models For CNS Drug Delivery | Prisys BiotechQuantitative in vivo biodistribution of CNS drug delivery systems using PET/CT imaging in NHP models. Supporting translational research and nose-to-brain delivery evaluation. -
Mar 23, 2026Large-Animal Radiolabeling And In Vivo Imaging Platform For Translational Dru...Explore how radiolabeling and clinical imaging in non-human primates enable accurate in vivo PK and biodistribution data, supporting translational drug development. -
Mar 18, 2026Why Drug Development Increasingly Relies On NHP Models: The Essential Role Of...why non-human primate (NHP) models, such as cynomolgus and rhesus macaques, are essential for modern drug development and translational medicine. It highlights the biological, g... -
Mar 17, 2026IPF Drug Development Challenges And Solutions | NHP Models With CT Imaging & PFTExplore how advanced NHP pulmonary fibrosis models, quantitative CT imaging, and pulmonary function testing improve translational success in IPF drug development. -
Mar 11, 2026AI Markerless NHP 3D Behavior Analysis System For Preclinical ResearchLearn how the AI-based NBAS markerless 3D behavior analysis system enables accurate non-human primate behavioral tracking for neuroscience and drug development studies. -
Mar 10, 2026Evaluating DMPK Properties Of Candidate Compounds in Early Drug Discovery | P...Learn how key pharmacokinetic parameters—including clearance, volume of distribution, half-life, oral bioavailability, and exposure—are used to evaluate DMPK properties of candi... -
Feb 25, 2026MRI-Guided CNS Delivery in NHP Models | Translational IMRI & CED PlatformPrisys Biotech offers MRI-guided precision CNS delivery in NHP models, integrating intraprocedural MRI and convection-enhanced delivery (CED) to support translational gene thera... -
Feb 14, 2026NHP CNS Biodistribution Studies | Intrathecal RNA Delivery | PRISYS BiotechOptimize your RNA therapeutic pipeline with NHP CNS biodistribution studies. Featuring precision intrathecal delivery, imaging-guided administration, and regional brain analysis... -
Feb 13, 2026Translational PK/PD Framework: Cynomolgus Monkey To Human Dose Prediction | P...Explore a structured translational PK/PD framework integrating in vitro pharmacology and NHP models to refine human dose prediction and clinical proof-of-concept.
